OPK
OPKO HEALTH, INC.
Key Financials
Gross Profit
$205.9M
↓ 5.8%
Net Income
$-225680000
↓ 622.0%
Operating Income
$-117409000
↑ 22.8%
Revenue
$606.9M
↑ 308.8%
Total Assets
$1.9B
↓ 12.2%
Total Liabilities
$664.0M
↓ 20.5%
EPS (Diluted)
$-0.30
↓ 650.0%
Cash & Equivalents
$364.4M
↓ 14.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 3/20/2026 | View on SEC |
| 4 | 3/20/2026 | View on SEC |
| 3 | 3/20/2026 | View on SEC |
| 8-K | 3/19/2026 | View on SEC |
| 10-K | 2/26/2026 | View on SEC |
| 8-K | 2/26/2026 | View on SEC |
| 4 | 11/21/2025 | View on SEC |
| 4 | 11/20/2025 | View on SEC |
| 4 | 11/19/2025 | View on SEC |
| 4 | 11/18/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | OPK |
| Company Name | OPKO HEALTH, INC. |
| CIK | 944809 |
| Sector | Pharmaceutical Preparations |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 305-575-4181 |